ARTHEx Biotech
PrivateLast Round
Series B
Sep 17, 2025
Total Funding Raised
$95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ARTHEx Biotech is a biotechnology company that develops targeted RNA medicines for rare genetic neuromuscular disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARTHEx Biotech Comparables
Compare ARTHEx Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novartis | 83% | |
| PepGen | 81% | |
| Juvena Therapeutics | 81% | |
ARTHEx Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 17, 2025 | ||||
| Series A | Jul 20, 2022 | ||||
| Seed | Jul 23, 2020 | ||||
| Seed | Jun 1, 2020 |
Key People
Founding team and executive leadership
ARTHEx Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series B |
| Hadean Ventures | Series B |
| Center for Technological Development and Innovation | Seed, Series B |
| Invivo Partners | Seed, Series B |
| Columbus Venture Partners | Series B |
| European Union Funding Programmes | Series B |
| Bpifrance | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 117% MoM.
- May 17, 2026
Monthly visitors increased 67% MoM.
ARTHEx Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ARTHEx Biotech's valuation, stock price, and market status.